Letters
Patient Stories
Next chapter
Q&A
Corporate responsibility
Next Wave
Business Development
Development Pipeline
Our People
Corporate Information
Stockholder Information
Downloads
Working together for patients
2015 Annual Report
Brenda Cushing, diagnosed with non-small cell lung cancer, is now being treated with an Immuno-Oncology therapy from Bristol-Myers Squibb.
Bristol-Myers Squibb Company
345 Park Avenue • New York, NY 10154-0037
212-546-4000 •
www.bms.com